Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Barbara Zaggia

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Current Opinion in Endocrinology, Diabetes, and Obesity|April 16, 2014
Practical treatment using mitotane for adrenocortical carcinomaMassimo Terzolo, Barbara Zaggia, Barbara Allasino, et al.
European Urology|February 9, 2010
Retrospective evaluation of the outcome of open versus laparoscopic adrenalectomy for stage I and II adrenocortical cancerFrancesco Porpiglia, Cristian Fiori, Fulvia Daffara, et al.
International Journal of Endocrinology|June 16, 2015
Evaluation of Midnight Salivary Cortisol as a Predictor Factor for Common Carotid Arteries Intima Media Thickness in Patients with Clinically Inapparent Adrenal AdenomasGiuseppe Reimondo, Barbara Allasino, Marcella Coletta, et al.
Human Pathology|December 6, 2016
Validation of the prognostic role of the "Helsinki Score" in 225 cases of adrenocortical carcinomaEleonora Duregon, Rocco Cappellesso, Valeria Maffeis, et al.
Human Pathology|October 17, 2015
Pitfalls in the diagnosis of adrenocortical tumors: a lesson from 300 consultation casesEleonora Duregon, Marco Volante, Enrico Bollito, et al.
European Journal of Endocrinology|August 7, 2017
Effects of mitotane on the hypothalamic-pituitary-adrenal axis in patients with adrenocortical carcinomaGiuseppe Reimondo, Soraya Puglisi, Barbara Zaggia, et al.
European Journal of Endocrinology|August 21, 2008
The combined low-dose dexamethasone suppression corticotropin-releasing hormone test as a tool to rule out Cushing's syndromeGiuseppe Reimondo, Silvia Bovio, Barbara Allasino, et al.
Pharmacogenetics and Genomics|March 26, 2013
Influence of the CYP2B6 polymorphism on the pharmacokinetics of mitotaneAntonio D'Avolio, Silvia De Francia, Vittoria Basile, et al.
Endocrine-Related Cancer|October 1, 2008
Prospective evaluation of mitotane toxicity in adrenocortical cancer patients treated adjuvantlyFulvia Daffara, Silvia De Francia, Giuseppe Reimondo, et al.
The Journal of Clinical Endocrinology and Metabolism|March 22, 2017
Long-Term Outcomes of Adjuvant Mitotane Therapy in Patients With Radically Resected Adrenocortical CarcinomaAlfredo Berruti, Salvatore Grisanti, Alina Pulzer, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Current Opinion in Endocrinology, Diabetes, and Obesity|April 16, 2014
Practical treatment using mitotane for adrenocortical carcinomaMassimo Terzolo, Barbara Zaggia, Barbara Allasino, et al.
European Urology|February 9, 2010
Retrospective evaluation of the outcome of open versus laparoscopic adrenalectomy for stage I and II adrenocortical cancerFrancesco Porpiglia, Cristian Fiori, Fulvia Daffara, et al.
International Journal of Endocrinology|June 16, 2015
Evaluation of Midnight Salivary Cortisol as a Predictor Factor for Common Carotid Arteries Intima Media Thickness in Patients with Clinically Inapparent Adrenal AdenomasGiuseppe Reimondo, Barbara Allasino, Marcella Coletta, et al.
Human Pathology|December 6, 2016
Validation of the prognostic role of the "Helsinki Score" in 225 cases of adrenocortical carcinomaEleonora Duregon, Rocco Cappellesso, Valeria Maffeis, et al.
Human Pathology|October 17, 2015
Pitfalls in the diagnosis of adrenocortical tumors: a lesson from 300 consultation casesEleonora Duregon, Marco Volante, Enrico Bollito, et al.
European Journal of Endocrinology|August 7, 2017
Effects of mitotane on the hypothalamic-pituitary-adrenal axis in patients with adrenocortical carcinomaGiuseppe Reimondo, Soraya Puglisi, Barbara Zaggia, et al.
European Journal of Endocrinology|August 21, 2008
The combined low-dose dexamethasone suppression corticotropin-releasing hormone test as a tool to rule out Cushing's syndromeGiuseppe Reimondo, Silvia Bovio, Barbara Allasino, et al.
Pharmacogenetics and Genomics|March 26, 2013
Influence of the CYP2B6 polymorphism on the pharmacokinetics of mitotaneAntonio D'Avolio, Silvia De Francia, Vittoria Basile, et al.
Endocrine-Related Cancer|October 1, 2008
Prospective evaluation of mitotane toxicity in adrenocortical cancer patients treated adjuvantlyFulvia Daffara, Silvia De Francia, Giuseppe Reimondo, et al.
The Journal of Clinical Endocrinology and Metabolism|March 22, 2017
Long-Term Outcomes of Adjuvant Mitotane Therapy in Patients With Radically Resected Adrenocortical CarcinomaAlfredo Berruti, Salvatore Grisanti, Alina Pulzer, et al.
Pageof 2